BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 25443224)

  • 1. [Role of thiopurine agents in ulcerative colitis].
    Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():30-5. PubMed ID: 25443224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.
    Bermejo F; Aguas M; Chaparro M; Domènech E; Echarri A; García-Planella E; Guerra I; Gisbert JP; López-Sanromán A;
    Gastroenterol Hepatol; 2018 Mar; 41(3):205-221. PubMed ID: 29357999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
    J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
    Axelrad JE; Roy A; Lawlor G; Korelitz B; Lichtiger S
    World J Gastroenterol; 2016 Dec; 22(46):10103-10117. PubMed ID: 28028358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?
    Ghosh S; Chaudhary R; Carpani M; Playford RJ
    Gut; 2006 Jan; 55(1):6-8. PubMed ID: 16344570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next steps on the thiopurine methyltransferase 6-thioguanine nucleotide pathway.
    Colletti RB
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):282-3. PubMed ID: 16954947
    [No Abstract]   [Full Text] [Related]  

  • 8. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
    Ledder O; Lemberg DA; Day AS
    Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.
    Dubinsky MC
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):731-43. PubMed ID: 15354273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol.
    Smith MA; Blaker P; Marinaki AM; Anderson SH; Irving PM; Sanderson JD
    J Crohns Colitis; 2012 Oct; 6(9):905-12. PubMed ID: 22386736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances using immunomodulators for inflammatory bowel disease.
    Nielsen OH; Bjerrum JT; Herfarth H; Rogler G
    J Clin Pharmacol; 2013 Jun; 53(6):575-88. PubMed ID: 23408468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiopurines in Crohn's disease, is there something new?
    Miheller P; Lakatos PL
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1505-14. PubMed ID: 20919963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and response to thiopurines in patients with inflammatory bowel disease.
    Goldberg R; Irving PM
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):891-900. PubMed ID: 25915575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Azathioprine].
    Sasaki M; Fujiyama Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():692-9. PubMed ID: 15954431
    [No Abstract]   [Full Text] [Related]  

  • 17. How thiopurines are used for the treatment of inflammatory bowel diseases: an Italian survey.
    Saibeni S; Kohn A; Meucci G; Papi C;
    Dig Liver Dis; 2015 Feb; 47(2):170-3. PubMed ID: 25467827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Azathioprine in chronic inflammatory bowel diseases. Evidence base].
    Herrlinger K; Stange EF
    Med Klin (Munich); 2000 Apr; 95(4):201-6. PubMed ID: 10808301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase.
    Roberts-Thomson IC; Butler WJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):955. PubMed ID: 15946151
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI
    Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.